BOTZ vs XLV
Global X Robotics & Artificial Intelligence ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.68% for BOTZ.
- • XLV pays a higher dividend yield (1.38%).
Side-by-side metrics
| Metric | BOTZ | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.68% | 0.08% |
Dividend yield Trailing 12-month yield. | 0.54% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $3.04B | $49.10B |
YTD return | -11.96% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.86 | 0.41 |
P/E ratio | 35.20 | 30.63 |
Last price | $32.39 | $187.94 |
Inception | — | — |
Issuer | Global X | State Street |
BOTZ top holdings
| ISRG | Intuitive Surgical Inc | 9.94% |
| 6861.T | Keyence Corp | 8.65% |
| 6954.T | Fanuc Corp | 8.59% |
| NVDA | NVIDIA Corp | 7.81% |
| ABBN.SW | ABB Ltd | 7.71% |
| 6273.T | SMC Corp | 4.67% |
| 6383.T | Daifuku Co Ltd | 3.43% |
| 300124.SZ | Shenzhen Inovance Technology Co Ltd Class A | 2.93% |
| CGNX | Cognex Corp | 2.60% |
| TSLA | Tesla Inc | 2.40% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About BOTZ
BOTZ (Global X Robotics & Artificial Intelligence ETF) is Robotics, automation, and AI companies globally. Managed by Global X, the fund carries $3.0B in assets under management, an expense ratio of 0.68%, a dividend yield of 0.54%. Its largest holding is Intuitive Surgical Inc (ISRG), which represents 9.9% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 5.7%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.